Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Bio-Rad Laboratories, Inc. (BIO) had Weighted-Average Shares Outstanding (Diluted) of 27.01M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$693.20M |
|
$720.00M |
|
$348.00M |
|
$345.20M |
|
$812.10M |
|
$-118.90M |
|
$1.05B |
|
$929.20M |
|
$-100.30M |
|
$720.00M |
|
$720.00M |
|
$720.00M |
|
$-541.28M |
|
$-118.90M |
|
-- |
|
26.98M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
27.01M |
$26.69 |
|
$26.65 |
|
| Balance Sheet Financials | |
$2.91B |
|
$539.90M |
|
$7.67B |
|
$10.58B |
|
$517.00M |
|
$1.20B |
|
$2.61B |
|
$3.12B |
|
-- |
|
$6.70B |
|
$7.45B |
|
-- |
|
| Cash Flow Statement Financials | |
$532.20M |
|
$-189.70M |
|
$-283.20M |
|
$489.80M |
|
$532.20M |
|
$42.40M |
|
$58.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|